If you're doing any kind of automotive wiring—whether it's for off-road lights, engine swaps, or just fixing up old harnesses ...

MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

While the American car market was booming in the '50s, independent carmakers were struggling in the face of the financial ...

Pharmaceutical distributor Cencora will invest $1 billion in its U.S. supply chain as demand soars for cancer therapies, weight-loss drugs such as Ozempic and other medications that need special ...

What just happened? The market for single-board computers continues to expand, creating new opportunities for both Arm- and x86-based products. MSI is launching a new single-board computer aimed at ...

Adam Piekarski decided to go it alone after more than a decade at BDT & MSD Partners. He’s backing up that bet with a historic unveiling. Derby Lane Partners has amassed $1.8 billion in commitments ...

The dynamic, innovative, and agile environment that is the pharmaceutical industry requires a particular set of skills. For MSD Ireland, one of the country’s largest healthcare companies with eight ...

MSD's plan to reduce its headcount by around 6,000, first revealed a couple of weeks ago, looks like it will start at its headquarters in Rahway, New Jersey. Confirmation of that has come in the form ...

Part 3: It took a few tweaks and old-school tricks to get max power from our small-block Chevy that we built at TPS Motorsports. First Look: Summit SPC Engine Block Part 1: Summit Racing 427 ...

Summit founder and president Quint Rubald, CEO Jeff Evrard and the broader management team will remain shareholders and continue to lead the company Founded in 1999, Summit has locations across 37 ...

MSD is slashing $3bn (€2.59bn) from its annual spending as it braces for off-brand competition to its Irish-manufactured cancer drug Keytruda, the best-selling medicine in the world. The drugmaker ...

SBC Medical Group Holdings (NASDAQ:SBC), which provides end-to-end solutions enabling aesthetics clinics to launch, expand and/or operate their businesses, is expected to report 2Q25 results within ...